John R. Heard, MD, MS
@john_r_heard
Urology Resident at Cedars-Sinai | Interested in biotech, oncology, virus engineering, and gene therapy ๐งฌ๐ฆ | Husband of a Turk ๐น๐ท | ๐ดโโ๏ธ๐โโ๏ธโท๐ฅenthusiast
ID:908433442139967488
http://www.linkedin.com/in/JohnRobinsonHeard 14-09-2017 20:53:05
187 Tweets
383 Followers
444 Following
SYSTEMATIC REVIEW ๐Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available Assays ๐ by John R. Heard, MD, MS Anirban Mitra Cedars-Sinai Cancer at Cedars-Sinai Cedars-SinaiMed content.iospress.com/articles/bladdโฆ Dr. Bishoy M. Faltas Dan Theodorescu splernerMD
Congratulations to Andrew J. Hung, MD for giving the Bulkey-Barry-Cooper professorial lecture yesterday on 'Automation of Skills Assessment in Robotic Surgeryโ at King's College London!
Pictured is Dr. Hung with his host Prof. Prokar Dasgupta OBE, Chair in Robotic Surgery and Urological Innovation
It's the best day of the year!! We are so excited to match Julie Solomon from WashU Urology and Timothy Chu from USC Urology! Welcome to the family - and congrats to all who matched today!
Cedars-Sinai Cedars-SinaiMed Amer. Urol. Assn. #UroMatch2024
What makes a great urology sub-internship? Please help us improve the sub-i experience for all by completing this 5 minute survey. Link below! There is also a chance to win a $50 dollar amazon gift card. Thank you!
t.ly/zfLc9
UroResidency The Urology Applicant โ Amer. Urol. Assn.
The best part of #aua2023 was meeting new people. I was fortunate to meet TWO urologists from Turkey ๐น๐ท Selcuk Erdem (pictured) and Dr. Ali Riza Kural. They were incredibly kind and I hope to visit them in Istanbul later this year.
Tรผrk รroloji Derneฤi Amer. Urol. Assn.
Early Cedars-Sinai highlights from #AUA2023 with two best posters and a reminder of Timothy Daskivichโs award from Urology Care Foundation.
Congrats to John M. Masterson and Maurice Garcia MD for their best poster awards
Urology Graduate Medical Education at Cedars-Sinai Cancer at Cedars-Sinai
Excited to announce results from the EMBARK study which I co-led with neal shore. Results show benefit of enzalutamide to delay metastasis-free survival in hi-risk biochemically recurrent prostate cancers. Cedars-Sinai Cancer at Cedars-Sinai Pfizer Inc. Astellas Pharma US
pfizer.com/news/press-relโฆ
Fantastic grand rounds on hereditary kidney cancer this morning! Big thanks to Mark Ball, MD, FACS NCI Center for Cancer Research
NIH @CSCancerCare Cedars-Sinai